Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

Cited by (1,006)

Items 101–200 of 1,006

1. Latent Representation Learning for Alzheimer’s Disease Diagnosis With Incomplete Multi-Modality Neuroimaging and Genetic Data
   Tao Zhou, Mingxia Liu, Kim‐Han Thung, Dinggang G. Shen · 2019 · IEEE Transactions on Medical Imaging
2. Sex and Gender Differences in Alzheimer's Disease: Recommendations for Future Research
   Carter, Christine L., Resnick, Eileen M., Mallampalli, Monica, Kalbarczyk, Anna · 2012 · Journal of Women's Health
3. Cystatin C-Cathepsin B Axis Regulates Amyloid Beta Levels and Associated Neuronal Deficits in an Animal Model of Alzheimer's Disease
   Sun, Binggui, Zhou, Yungui, Halabisky, Brian, Lo, Iris, Cho, Seo-Hyun, Mueller-Steiner, Sarah, Devidze, Nino, Wang, Xin, Grubb, Anders, Gan, Li · 2008 · Neuron
4. Meta-analysis of Telomere Length in Alzheimer’s Disease
   Forero, Diego A., González-Giraldo, Yeimy, López-Quintero, Catalina, Castro-Vega, Luis J., Barreto, George E., Perry, George · 2016 · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences
5. Effect of APOE ε4 Status on Intrinsic Network Connectivity in Cognitively Normal Elderly Subjects
   Mary M. Machulda, David Thomas Jones, Prashanthi Vemuri, Eric McDade, Ramesh T. V. Avula, Scott A. Przybelski, Bradley F. Boeve, David S. Knopman, Ronald Carl Petersen, Clifford R. Jack · 2011 · Archives of Neurology
6. The Central Nervous System
   Matthew P. Frosch, Douglas C. Anthony, Umberto De Girolami · 2010 · Elsevier eBooks
7. Peroxisomal alterations in Alzheimer’s disease
   Kou, Jianqiu, Kovacs, Gabor G., Höftberger, Romana, Kulik, Willem, Brodde, Alexander, Forss-Petter, Sonja, Hönigschnabl, Selma, Gleiss, Andreas, Brügger, Britta, Wanders, Ronald et al. · 2011 · Acta Neuropathologica
8. MicroRNA: Implications for Alzheimer Disease and other Human CNS Disorders
   Olivier C. Maes, Howard Mark Chertkow, Eugenia Wang, Hyman M. Schipper · 2009 · Current Genomics
9. Genetics of Alzheimer’s Disease
   Vincent Antoine Chouraki, Sudha S. Seshadri · 2014 · Advances in genetics
10. Alzheimer's therapeutics: Continued clinical failures question the validity of the amyloid hypothesis—but what lies beyond?
    Kevin Mullane, Michael J. Williams · 2012 · Biochemical Pharmacology
11. Cholesterol involvement in the pathogenesis of neurodegenerative diseases
    Junping Liu, Ying Tang, Shufeng Zhou, Ban Hock Toh, Catriona McLean, He Li · 2009 · Molecular and Cellular Neuroscience
12. Molecular genetics of Alzheimer's disease: An update
    Nathalie Brouwers, Kristel Sleegers, Christine Van Broeckhoven · 2008 · Annals of Medicine
13. APOE and Alzheimer’s Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer’s Pathogenesis
    Uddin, Md. Sahab, Kabir, Md. Tanvir, Al Mamun, Abdullah, Abdel-Daim, Mohamed M., Barreto, George E., Ashraf, Ghulam Md · 2019 · Molecular Neurobiology
14. Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm
    Jiajun Shi, Jacqueline K. Wittke‐Thompson, Judith Ann Badner, Eiji Hattori, James B. Potash, Virginia L. Willour, Francis J. McMahon, Elliot S. Gershon, Chunyu Liu · 2008 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
15. Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins
    Huynh, Tien-Phat V., Davis, Albert A., Ulrich, Jason D., Holtzman, David M. · 2017 · Journal of Lipid Research
16. Age-Dependent Effects of apoE Reduction Using Antisense Oligonucleotides in a Model of β-amyloidosis
    Huynh, Tien-Phat V., Liao, Fan, Francis, Caroline M., Robinson, Grace O., Serrano, Javier Remolina, Jiang, Hong, Roh, Joseph, Finn, Mary Beth, Sullivan, Patrick M., Esparza, Thomas J. et al. · 2017 · Neuron
17. Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls
    Fotini K. Kavvoura, John P. A. Ioannidis · 2007 · Human Genetics
18. MicroRNAs can regulate human APP levels
    Neha Patel, David M. Hoang, Nathan Miller, Sara Ansaloni, Qihong Huang, Jack T. Rogers, Jeremy C. Lee, Aleister J. Saunders · 2008 · Molecular Neurodegeneration
19. Replication of CLU, CR1, and PICALM Associations With Alzheimer Disease
    Carrasquillo, Minerva M., Belbin, Olivia, Hunter, Talisha A., Ma, Li, Bisceglio, Gina D., Zou, Fanggeng, Crook, Julia E., Pankratz, V. Shane, Dickson, Dennis W., Graff-Radford, Neill R. et al. · 2010 · Archives of Neurology
20. The sinister face of heme oxygenase-1 in brain aging and disease
    Hyman M. Schipper, Wei Song, Ayda Tavitian, Marisa Cressatti · 2018 · Progress in Neurobiology
21. The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease
    Lill, Christina M., Rengmark, Aina, Pihlstrøm, Lasse, Fogh, Isabella, Shatunov, Aleksey, Sleiman, Patrick M., Wang, Li‐San, Liu, Tian, Lassen, Christina F., Meissner, Esther et al. · 2015 · Alzheimer's & Dementia
22. CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer’s Disease
    Bence György, Camilla Lööv, Mikołaj Piotr Zaborowski, Shuko Takeda, Benjamin P. Kleinstiver, Caitlin Commins, Ksenia V. Kastanenka, Dakai Mu, Adrienn Volak, Vilmantas Giedraitis et al. · 2018 · Molecular Therapy — Nucleic Acids
23. Emerging roles of pathogens in Alzheimer disease
    Judith Miklossy · 2011 · Expert Reviews in Molecular Medicine
24. APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge
    Lee, Sangderk, Devanney, Nicholas A., Golden, Lesley R., Smith, Cathryn T., Schwartz, James L., Walsh, Adeline E., Clarke, Harrison A., Goulding, Danielle S., Allenger, Elizabeth J., Morillo-Segovia, Gabriella et al. · 2023 · Cell Reports
25. Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology
    Kehoe, Patrick Gavin, Wong, Steffenny, AL Mulhim, Noura, Palmer, Laura Elyse, Miners, J. Scott · 2016 · Alzheimer's Research & Therapy
26. Cerebrospinal fluid immune dysregulation during healthy brain aging and cognitive impairment
    Natalie Piehl, Lynn van Olst, Abhirami Ramakrishnan, Victoria Teregulova, Brooke Simonton, Ziyang Zhang, Emma Tapp, Divya Channappa, Hamilton Se‐Hwee Oh, Patricia Morán Losada et al. · 2022 · Cell
27. Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease
    Chapuis, J, Hot, D, Hansmannel, F, Kerdraon, O, Ferreira, S, Hubans, C, Maurage, C A, Huot, L, Bensemain, F, Laumet, G et al. · 2009 · Molecular Psychiatry
28. Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham study
    Sudha S. Seshadri, Anita L. DeStefano, Rhoda Au, Joseph M. Massaro, Alexa Beiser, Margaret Kelly‐Hayes, Carlos S. Kase, Ralph B. D’Agostino, Charles S DeCarli, Larry D. Atwood et al. · 2007 · BMC Medical Genetics
29. Bridging integrator 1 (BIN1): form, function, and Alzheimer's disease
    Meng‐Shan Tan, Jin‐Tai Yu, Lan Tan · 2013 · Trends in Molecular Medicine
30. APOE2 enhances neuroprotection against Alzheimer’s disease through multiple molecular mechanisms
    Conejero-Goldberg, C, Gomar, J J, Bobes-Bascaran, T, Hyde, T M, Kleinman, J E, Herman, M M, Chen, S, Davies, P, Goldberg, T E · 2014 · Molecular Psychiatry
31. Peripheral clearance of brain-derived Aβ in Alzheimer's disease: pathophysiology and therapeutic perspectives
    Yuan Cheng, Ding‐Yuan Tian, Yan-Jiang Wang · 2020 · Translational Neurodegeneration
32. Pharmacogenetics in major depression: A comprehensive meta-analysis
    Tomihisa Niitsu, Chiara Fabbri, Francesco Bentini, Alessandro Serretti · 2013 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
33. Alzheimer's Disease: Redox Dysregulation As a Common Denominator for Diverse Pathogenic Mechanisms
    Rommy von Bernhardi M., Jaime L. Eugenín · 2011 · Antioxidants and Redox Signaling
34. GABAergic dysfunction, neural network hyperactivity and memory impairments in human aging and Alzheimer’s disease
    Joan Jiménez-Baladó, Teal S. Eich · 2021 · Seminars in Cell and Developmental Biology
35. Elucidating Molecular Phenotypes Caused by the SORL1 Alzheimer’s Disease Genetic Risk Factor Using Human Induced Pluripotent Stem Cells
    Jessica E. Young, Jonathan Boulanger-Weill, Daniel A. Williams, Grace Woodruff, Floyd Buen, Arra C Revilla, Cheryl M. Herrera, Mason A. Israel, Shauna H. Yuan, Steven D. Edland et al. · 2015 · Cell stem cell
36. Alzheimer's disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline
    Yevgen Chornenkyy, Wang‐Xia Wang, Angela L. Wei, Peter T. Nelson · 2018 · Brain Pathology
37. Neuronal dark matter: the emerging role of microRNAs in neurodegeneration
    Goodall, Emily F., Heath, Paul R., Bandmann, Oliver, Kirby, Janine, Shaw, Pamela J. · 2013 · Frontiers in Cellular Neuroscience
38. Systematic Reviews of Genetic Association Studies
    Gurdeep Singh Sagoo, Julian Little, Julian P. T. Higgins · 2009 · PLoS Medicine
39. Apolipoprotein C1: Its Pleiotropic Effects in Lipid Metabolism and Beyond
    Fuior, Elena V., Gafencu, Anca V. · 2019 · International Journal of Molecular Sciences
40. Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders.
    Vijay K. Ramanan, Andrew J. Saykin · 2013 · Europe PMC (PubMed Central)
41. Targeting microglia for the treatment of Alzheimer’s Disease
    Wes, Paul D., Sayed, Faten A., Bard, Frédérique, Gan, Li · 2016 · Glia
42. Genomic variants, genes, and pathways of Alzheimer's disease: An overview
    Adam Christian Naj, Gerard D. Schellenberg · 2016 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
43. Prediction of Alzheimer's disease based on deep neural network by integrating gene expression and DNA methylation dataset
    Park, Chihyun, Ha, Jihwan, Park, Sanghyun · 2020 · Expert Systems with Applications
44. The genetics of Alzheimer's disease
    Eva Bagyinszky, Young Chul Youn, Seong Soo A. An, SangYun Kim · 2014 · Clinical Interventions in Aging
45. Role of the P-Type ATPases, ATP7A and ATP7B in brain copper homeostasis
    Jonathon Telianidis, Ya Hui Hung, Stephanie Materia, Sharon La Fontaine · 2013 · Frontiers in Aging Neuroscience
46. Identifying quantitative trait loci via group-sparse multitask regression and feature selection: an imaging genetics study of the ADNI cohort
    Hua Wang, Feiping Nie, Heng Huang, Sungeun Kim, Kwangsik T. Nho, Shannon L. Risacher, Andrew J. Saykin, Li Shen, Alzheimer’s Disease Neuroimaging Initiative · 2011 · Bioinformatics
47. Role of the mitochondrial DNA replication machinery in mitochondrial DNA mutagenesis, aging and age-related diseases
    DeBalsi, Karen L., Hoff, Kirsten E., Copeland, William C. · 2017 · Ageing Research Reviews
48. Neuronal ROS-Induced Glial Lipid Droplet Formation is Altered by Loss of Alzheimer's Disease-Associated Genes
    Moulton, Matthew J., Barish, Scott, Ralhan, Isha, Chang, Jinlan, Goodman, Lindsey D., Harland, Jake G., Marcogliese, Paul C., Johansson, Jan O., Ioannou, Maria S., Bellen, Hugo J. · 2021 · Proceedings of the National Academy of Sciences
49. Genome-Wide Scan Informed by Age-Related Disease Identifies Loci for Exceptional Human Longevity
    Kristen Fortney, Edgar Dobriban, Paolo Garagnani, Chiara Pirazzini, Daniela Monti, Daniela Mari, Gil Atzmon, Nir Barzilai, Claudio Franceschi, Art B. Owen et al. · 2015 · PLoS Genetics
50. AutismKB: an evidence-based knowledgebase of autism genetics
    Xu, Li-Ming, Li, Jia-Rui, Huang, Yue, Zhao, Min, Tang, Xing, Wei, Liping · 2012 · Nucleic Acids Research
51. The Impact of Multifunctional Genes on "Guilt by Association" Analysis
    Jesse Gillis, Paul Pavlidis · 2011 · PLoS ONE
52. Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer’s Disease
    Yanan Sun, Cao Ma, Hui Juan Sun, Huan Wang, Peng Wei, Zibo Zhou, Hongwei Wang, Chenchen Pi, Yingai Shi, Xu He · 2020 · Journal of Diabetes Research
53. Role of apolipoprotein E in neurodegenerative diseases
    Vo Van Giau, Eva Bagyinszky, Seong Soo A. An, SangYun Kim · 2015 · Neuropsychiatric Disease and Treatment
54. Apolipoprotein E and Alzheimer's disease
    Benjamin Troutwine, Laylan Hamid, Colton R Lysaker, Taylor A. Strope, Heather Wilkins · 2021 · Acta Pharmaceutica Sinica B
55. Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers
    Alzheimer’s Disease Neuroimaging Initiative, Li Shen, Paul M. Thompson, Steven G. Potkin, Lars Bertram, Lindsay A. Farrer, Tatiana Foroud, Robert C. Green, Xiaolan Hu, Matthew J. Huentelman et al. · 2013 · Brain Imaging and Behavior
56. Chronic traumatic encephalopathy in contact sports: A systematic review of all reported pathological cases
    Maroon, Joseph C., Winkelman, Robert, Bost, Jeffrey, Amos, Austin, Mathyssek, Christina, Miele, Vincent · 2015 · PLoS ONE
57. Common Alzheimer's Disease Risk Variant Within the CLU Gene Affects White Matter Microstructure in Young Adults
    Meredith N. Braskie, Neda Jahanshad, Jason L. Stein, Marina Barysheva A, Katie Louise McMahon, Greig Ian de Zubicaray, Nicholas G. Martin, Margaret J. Wright, John Matthew Ringman, Arthur W. Toga et al. · 2011 · Journal of Neuroscience
58. The Role of Clusterin in Alzheimer’s Disease: Pathways, Pathogenesis, and Therapy
    Yu, Jin-Tai, Tan, Lan · 2012 · Molecular Neurobiology
59. Trajectories of cognitive decline in Alzheimer's disease
    Patricia A. Wilkosz, Howard J. Seltman, Bernie Devlin, Elise A. Weamer, Oscar L. López, Steven Trent DeKosky, Robert A. Sweet · 2009 · International Psychogeriatrics
60. Differential expression of microRNAs in Alzheimer's disease brain, blood, and cerebrospinal fluid
    Takousis, Petros, Sadlon, Angélique, Schulz, Jessica, Wohlers, Inken, Dobricic, Valerija, Middleton, Lefkos, Lill, Christina M., Perneczky, Robert, Bertram, Lars · 2019 · Alzheimer's & Dementia
61. Sphingolipids: Critical players in Alzheimer’s disease
    Gerhild van Echten‐Deckert, Jochen Walter · 2012 · Progress in Lipid Research
62. Current status on Alzheimer disease molecular genetics: from past, to present, to future
    Karolien Bettens, Kristel Sleegers, Christine Van Broeckhoven · 2010 · Human Molecular Genetics
63. Apolipoprotein E as a Therapeutic Target in Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence
    Yu Yamazaki, Meghan M. Painter, Guojun Bu, Takahisa Kanekiyo · 2016 · CNS Drugs
64. Increased Hippocampal Default Mode Synchronization during Rest in Middle-Aged and Elderly APOE ε4 Carriers: Relationships with Memory Performance
    Erling Tjelta Westlye, Arvid Lundervold, Helge Rootwelt, Astri Johansen Lundervold, Lars Tjelta Westlye · 2011 · Journal of Neuroscience
65. Noninvasive brain stimulation in Alzheimer's disease: Systematic review and perspectives for the future
    Catarina Freitas, Helena Mondragón-Llorca, Álvaro Pascual‐Leone · 2011 · Experimental Gerontology
66. Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer’s disease?
    Nalivaeva, Natalia N., Beckett, Caroline, Belyaev, Nikolai D., Turner, Anthony J. · 2012 · Journal of Neurochemistry
67. A Field Synopsis on Low-Penetrance Variants in DNA Repair Genes and Cancer Susceptibility
    Paolo Vineis, Maurizio Manuguerra, Fotini K. Kavvoura, Simonetta Guarrera, Alessandra Allione, Fabio Rosa, Alessandra Di Gregorio, Silvia Polidoro, Federica Saletta, John P. A. Ioannidis et al. · 2008 · JNCI Journal of the National Cancer Institute
68. Does Inorganic Mercury Play a Role in Alzheimer's Disease? A Systematic Review and an Integrated Molecular Mechanism
    Joachim Mutter, Annika Curth, Johannes Naumann, Richard C. Deth, Harald Walach · 2010 · Journal of Alzheimer s Disease
69. Bin1 and CD2AP polarise the endocytic generation of beta‐amyloid
    Ubelmann, Florent, Burrinha, Tatiana, Salavessa, Laura, Gomes, Ricardo, Ferreira, Cláudio, Moreno, Nuno, Guimas Almeida, Cláudia · 2017 · The EMBO Reports
70. Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes.
    2009 · PubMed Central
71. Angiotensins in Alzheimer's disease – friend or foe?
    Patrick G. Kehoe, James Scott Miners, Seth Love · 2009 · Trends in Neurosciences
72. Brain cholesterol in normal and pathological aging
    Martin, Mauricio, Dotti, Carlos G., Ledesma, Maria Dolores · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
73. Artificial Intelligence for Alzheimer’s Disease: Promise or Challenge?
    Carlo Fabrizio, Andrea Termine, Carlo Caltagirone, Giulia Maria Sancesario · 2021 · Diagnostics
74. Genetic associations with schizophrenia: Meta-analyses of 12 candidate genes
    Jiajun Shi, Elliot S. Gershon, Chunyu Liu · 2008 · Schizophrenia Research
75. Epigenetics of dementia: understanding the disease as a transformation rather than a state
    Bryan Maloney, Debomoy K. Lahiri · 2016 · The Lancet Neurology
76. AlzPathway: a comprehensive map of signaling pathways of Alzheimer’s disease
    Satoshi Mizuno, Risa Iijima, Soichi Ogishima, Masataka Kikuchi, Yukiko Matsuoka, Samik Ghosh, Tadashi Miyamoto, Akinori Miyashita, Ryozo Kuwano, Hiroshi Tanaka · 2012 · BMC Systems Biology
77. Toward more predictive genetic mouse models of Alzheimer’s disease
    Onos, Kristen D., Sukoff Rizzo, Stacey J., Howell, Gareth R., Sasner, Michael · 2016 · Brain Research Bulletin
78. A Genomewide Screen for Late-Onset Alzheimer Disease in a Genetically Isolated Dutch Population
    Liu, Fan, Arias-Vásquez, Alejandro, Sleegers, Kristel, Aulchenko, Yurii S., Kayser, Manfred, Sanchez-Juan, Pascual, Feng, Bing-Jian, Bertoli-Avella, Aida M., van Swieten, John, Axenovich, Tatiana I. et al. · 2007 · The American Journal of Human Genetics
79. Brain somatic mutations observed in Alzheimer’s disease associated with aging and dysregulation of tau phosphorylation
    Park, Jun Sung, Lee, Junehawk, Jung, Eun Sun, Kim, Myeong-Heui, Kim, Il Bin, Son, Hyeonju, Kim, Sangwoo, Kim, Sanghyeon, Park, Young Mok, Mook-Jung, Inhee et al. · 2019 · Nature Communications
80. Circulating levels of IL-1 family cytokines and receptors in Alzheimer’s disease: new markers of disease progression?
    Paola Italiani, Ilaria Puxeddu, Sabrina Napoletano, Emanuele Scala, Daniela Melillo, Simone Manocchio, Antonella Angiolillo, Paola Migliorini, Diana Boraschi, Emilia Vitale et al. · 2018 · Journal of Neuroinflammation
81. Predominant expression of Alzheimer’s disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts
    De Rossi, Pierre, Buggia-Prévot, Virginie, Clayton, Benjamin L. L., Vasquez, Jared B., van Sanford, Carson, Andrew, Robert J., Lesnick, Ruben, Botté, Alexandra, Deyts, Carole, Salem, Someya et al. · 2016 · Molecular Neurodegeneration
82. Integrative genomics identifies APOE ε4 effectors in Alzheimer's disease
    Hervé Rhinn, Ryousuke Fujita, Liang Qiang, Rong Cheng, Joseph Hyungwoo Lee, Asa Abeliovich · 2013 · Nature · Retracted
83. APOE-ε2 and APOE-ε4 Correlate With Increased Amyloid Accumulation in Cerebral Vasculature
    Nelson, Peter T., Pious, Nina M., Jicha, Gregory A., Wilcock, Donna M., Fardo, David W., Estus, Steven, Rebeck, G. William · 2013 · Journal of Neuropathology & Experimental Neurology
84. Cystatin C modulates cerebral β-amyloidosis
    Kaeser, Stephan A, Herzig, Martin C, Coomaraswamy, Janaky, Kilger, Ellen, Selenica, Maj-Linda, Winkler, David T, Staufenbiel, Matthias, Levy, Efrat, Grubb, Anders, Jucker, Mathias · 2007 · Nature Genetics
85. DNA Damage and Repair in Alzheimers Disease
    Coppede, Fabio, Migliore, Lucia · 2009 · Current Alzheimer Research
86. Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: A long-range point of view beyond 2020
    Harald Juergen Hampel, Simone Lista, Stefan Johannes Teipel, Francesco Garaci, Robert Nisticò, Kaj Blennow, Henrik Zetterberg, Lars Bertram, Charles J. Duyckaerts, Hovagim Bakardjian et al. · 2013 · Biochemical Pharmacology
87. Sparse reduced-rank regression detects genetic associations with voxel-wise longitudinal phenotypes in Alzheimer's disease
    Maria Vounou, Eva Janoušová, Robin Wolz, Jason L. Stein, Paul M. Thompson, Daniel Rueckert, Giovanni Montana · 2011 · NeuroImage
88. Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Aβ1‐42
    Jonathan M. Schott, Jonathan W. Bartlett, Nick C. Fox, Josephine Barnes, Alzheimer’s Disease Neuroimaging Initiative · 2010 · Annals of Neurology
89. Early dementia diagnosis and the risk of suicide and euthanasia
    Brian Draper, Carmelle Peisah, John A Snowdon, Henry Brodaty · 2010 · Alzheimer s & Dementia
90. Prediction of Alzheimer’s disease using blood gene expression data
    Taesic Lee, Hyunju Lee · 2020 · Scientific Reports
91. Genome-Wide Association Studies, Field Synopses, and the Development of the Knowledge Base on Genetic Variation and Human Diseases
    Muin J. Khoury, Lars Bertram, Paolo Boffetta, Adam S. Butterworth, Stephen Jacob Chanock, Siobhan M. Dolan, Isabel Fortier, Montserrat García‐Closas, MARTA L. GWINN, Julian P. T. Higgins et al. · 2009 · American Journal of Epidemiology
92. Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer’s disease
    Stein, Jason L., Hua, Xue, Morra, Jonathan H., Lee, Suh, Hibar, Derrek P., Ho, April J., Leow, Alex D., Toga, Arthur W., Sul, Jae Hoon, Kang, Hyun Min et al. · 2010 · NeuroImage
93. Mitochondrial Dysfunction and Immune Activation are Detectable in Early Alzheimer's Disease Blood
    Katie Lunnon, Zina M. Ibrahim, Petroula Proitsi, Anbarasu Lourdusamy, Stephen Newhouse, Martina Sattlecker, Simon J. Furney, Muzamil Saleem, Hilkka S. Soininen, Iwona Kłoszewska et al. · 2012 · Journal of Alzheimer s Disease
94. Meta‐Analysis Methods
    Thomas A Trikalinos, Georgia Salanti, Elias Zintzaras, John P. A. Ioannidis · 2008 · Advances in genetics
95. Genetic association study on in and around the APOE in late-onset Alzheimer disease in Japanese
    Norihiro Takei, Akinori Miyashita, Tamao Tsukie, Hiroyuki Arai, Takashi Asada, Masaki Imagawa, Mikio Shoji, Susumu Higuchi, Katsuya Urakami, Hideo Kimura et al. · 2009 · Genomics
96. Development of biomarkers to chart all Alzheimer's disease stages: The royal road to cutting the therapeutic Gordian Knot
    Harald Juergen Hampel, Simone Lista, Zaven S. Khachaturian · 2012 · Alzheimer s & Dementia
97. The COPD genetic association compendium: a comprehensive online database of COPD genetic associations
    Peter J. Castaldi, Michael H. Cho, Matthew Cohn, Fawn Langerman, Sienna L. Moran, Nestor G. Tarragona, Hala Moukhachen, Radhika Venugopal, Delvina Hasimja Saraqini, Esther Kao et al. · 2009 · Human Molecular Genetics
98. Clusterin as a therapeutic target
    Mark R. Wilson, Amina Zoubeidi · 2016 · Expert Opinion on Therapeutic Targets
99. Genetic Aspects of Alzheimer Disease
    Jennifer Williamson, Jill S. Goldman, Karen S. Marder · 2009 · The Neurologist
100. Amyloid Precursor Protein and Alzheimer’s Disease
     Orobets, Kseniia S., Karamyshev, Andrey L. · 2023 · International Journal of Molecular Sciences